Navigating the Future of Infectious Diseases Management Through Carbon Nanotubes: A Review.

  • Published In: Nano Life, 2026, v. 16, n. 2. P. 1 1 of 3

  • Database: Academic Search Ultimate 2 of 3

  • Authored By: Malhan, Arprita; Guleria, Mridul; Das, Ushasi; Majee, Sutapa Biswas; Singh, Sudarshan; Nagime, Pooja V.; Syukri, Dwi Marlina; Chidrawar, Vijay R.; Arania, Resti; Shafi, Sheeba 3 of 3

Abstract

Infectious diseases are illnesses caused by pathogenic microorganisms, including viruses, bacteria, fungi, and parasites. These diseases can be transmitted from one individual to another, as well as through contaminated food, water, and insect bites, infectious agents invade the body, multiply, and disrupt normal bodily functions, leading to various health issues. However, due to antimicrobial resistance, the need to develop nanoenabled medicine gained significant attention recently. The management of infectious diseases using carbon nanotubes (CNTs) is an emerging field that leverages the unique properties of these nanostructures for enhanced drug delivery and therapeutic applications. Therefore, this review explores the transformative potential of CNTs in the diagnosis, prevention, and treatment of infectious diseases. As global health challenges escalate due to emerging pathogens and increasing drug resistance, the need for innovative solutions becomes critical. Moreover, the review systematically examines the unique properties of CNTs, including their mechanical, thermal, and electrical characteristics, that make them suitable for various biomedical applications. Further, the review highlights recent advancements in CNTs-based technologies, focusing on their roles in biosensing, drug deliver, and antiviral agents. Furthermore, the review also discusses how CNTs enhance the sensitivity and specificity of diagnostic tools, enabling rapid detection of infectious agents. Additionally, the multifunctional capabilities of CNTs in therapeutic applications, such as targeted drug delivery and pathogen inactivation, are also discussed. Challenges related to the clinical translation of CNTs technologies, including safety, biocompatibility, and regulatory concerns, are critically analyzed. In addition, the review concludes with clinical data by emphasizing the need for interdisciplinary collaboration to harness the full potential of CNTs in the management of infectious diseases, paving the way for future research and development in this promising field. [ABSTRACT FROM AUTHOR]

Additional Information

  • Source:Nano Life. 2026/04, Vol. 16, Issue 2, p1
  • Document Type:Article
  • Subject Area:Life Sciences
  • Publication Date:2026
  • ISSN:1793-9844
  • DOI:10.1142/S1793984425300018
  • Accession Number:185910868
  • Copyright Statement:Copyright of Nano Life is the property of World Scientific Publishing Company and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.